JP2007514782A5 - - Google Patents

Download PDF

Info

Publication number
JP2007514782A5
JP2007514782A5 JP2006545691A JP2006545691A JP2007514782A5 JP 2007514782 A5 JP2007514782 A5 JP 2007514782A5 JP 2006545691 A JP2006545691 A JP 2006545691A JP 2006545691 A JP2006545691 A JP 2006545691A JP 2007514782 A5 JP2007514782 A5 JP 2007514782A5
Authority
JP
Japan
Prior art keywords
alkyl
group
pharmaceutically acceptable
compound according
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006545691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007514782A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039988 external-priority patent/WO2005061468A1/en
Publication of JP2007514782A publication Critical patent/JP2007514782A/ja
Publication of JP2007514782A5 publication Critical patent/JP2007514782A5/ja
Pending legal-status Critical Current

Links

JP2006545691A 2003-12-17 2004-12-01 ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法 Pending JP2007514782A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53037103P 2003-12-17 2003-12-17
US57626704P 2004-06-02 2004-06-02
PCT/US2004/039988 WO2005061468A1 (en) 2003-12-17 2004-12-01 Halogenated biaryl heterocyclic compounds and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2007514782A JP2007514782A (ja) 2007-06-07
JP2007514782A5 true JP2007514782A5 (cg-RX-API-DMAC10.html) 2008-02-07

Family

ID=34713773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006545691A Pending JP2007514782A (ja) 2003-12-17 2004-12-01 ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法

Country Status (6)

Country Link
US (2) US7129259B2 (cg-RX-API-DMAC10.html)
EP (1) EP1713785A1 (cg-RX-API-DMAC10.html)
JP (1) JP2007514782A (cg-RX-API-DMAC10.html)
AR (1) AR046782A1 (cg-RX-API-DMAC10.html)
TW (1) TW200526649A (cg-RX-API-DMAC10.html)
WO (1) WO2005061468A1 (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
TWI378092B (en) 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
US8428884B1 (en) 2003-07-14 2013-04-23 Rib-X Pharmaceuticals, Inc. Protein synthesis modulators
PT1656095E (pt) * 2003-08-18 2014-03-11 Novabay Pharmaceuticals Inc Aminoácidos n,n-dihalogenados e seus derivados
JP2007514782A (ja) * 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
JP2008500318A (ja) * 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 抗菌剤としての3−{4−(ピリジン−3−イル)フェニル}−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-鹵化胺基酸、n,n-二鹵化胺基酸與其衍生物;以及使用其之組合物與方法
EP1904489B1 (en) 2005-06-08 2011-01-26 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
TW200740779A (en) * 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
WO2007133803A2 (en) * 2006-05-15 2007-11-22 Rib-X Pharmaceuticals, Inc. Treatment of mycobacterial infections
TW200843787A (en) * 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them
US20090132514A1 (en) * 2007-11-16 2009-05-21 Iac Search & Media, Inc. method and system for building text descriptions in a search database
CN101965353B (zh) * 2008-03-26 2014-12-17 丹诺医药(苏州)有限公司 共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
CA2723262A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
RU2659792C1 (ru) 2008-10-10 2018-07-04 Мерк Шарп Энд Домэ Корп. Оксазолидиноны и способ их очистки
MX384300B (es) 2009-02-03 2025-03-14 Merck Sharp & Dohme Llc Forma cristalina del fosfato de dihidrogeno r) -3- (4- (2- (2-metiltetrazol-5-il) piridin-5-il) -3-fluorofenil) -5-hidroximetil oxazolidin-2-ona.
EP2230231A1 (de) * 2009-03-16 2010-09-22 Bayer CropScience AG Verfahren zur Herstellung von 2,2-Difluorethylamin-Derivaten durch Imin-Hydrierung
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
US20120208857A1 (en) 2009-10-13 2012-08-16 Burak Eric S Pharmaceutical Compositions
EA027791B1 (ru) 2010-11-24 2017-09-29 Мелинта Терапьютикс, Инк. Фармацевтические композиции
WO2014152332A1 (en) 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics
CA2967825A1 (en) 2014-11-14 2016-05-19 Melinta Therapeutics, Inc. Method for treating, preventing, or reducing the risk of skin infection
WO2017066964A1 (en) * 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
EP3914587A4 (en) * 2019-01-18 2022-11-23 Merck Sharp & Dohme LLC OXAZOLIDINONE COMPOUNDS AND USES THEREOF AS ANTIBACTERIAL AGENTS
CN113045477B (zh) * 2019-12-26 2022-11-01 中蓝晨光化工研究设计院有限公司 一种含氟伯胺中间体的制备方法
CN120794967A (zh) * 2024-04-10 2025-10-17 沈阳药科大学 联芳基噁唑烷酮类化合物及其应用

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348393A (en) 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
US5043443A (en) 1988-07-29 1991-08-27 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5130316A (en) 1988-07-29 1992-07-14 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
EP0610265B1 (en) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
DE69316240T2 (de) 1992-12-08 1998-05-20 Upjohn Co Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel
DE4425609A1 (de) 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
HRP970049A2 (en) 1996-02-06 1998-04-30 Bayer Ag New heteroaryl oxazolidinones
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
FI19992555A7 (fi) 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
WO1999033839A1 (en) * 1997-12-26 1999-07-08 Cheil Jedang Corporation Cephem derivatives and a method for producing the compounds and an antibacterial composition containing the compounds
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
CA2318969A1 (en) 1998-01-23 1999-07-29 Mikhail F. Gordeev Oxazolidinone combinatorial libraries, compositions and methods of preparation
GB9812019D0 (en) 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
EP1082323A2 (en) 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
TW572757B (en) 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
GB9821938D0 (en) 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
AU1379900A (en) 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel substituted phenyloxazolidone derivatives
CN1367780A (zh) 1999-07-28 2002-09-04 法玛西雅厄普约翰美国公司 噁唑烷酮类化合物、其制备方法及其应用
US6297242B1 (en) * 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
CN1186328C (zh) 1999-11-04 2005-01-26 巴斯利尔药物股份公司 取代的5-苄基-2,4-二氨基嘧啶
GB9928499D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical processes and intermediates
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
NZ522990A (en) 2000-06-05 2003-08-29 Dong A Pharm Novel oxazolidinone derivatives and a process for the preparation thereof
DE10034627A1 (de) 2000-07-17 2002-01-31 Bayer Ag Aryl-substituierte Oxazolidinone mit Cytokin inhibitorischer Wirkung
GB0108793D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
DE60212959T2 (de) 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
GB0108794D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compound
GB0108764D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0113297D0 (en) 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
GB0113299D0 (en) 2001-06-01 2001-07-25 Astrazeneca Ab Chemical process & intermediates
AU2002329393B2 (en) 2001-09-11 2008-06-12 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
WO2003035648A1 (en) 2001-10-25 2003-05-01 Astrazeneca Ab Aryl substituted oxazolidinones with antibacterial activity
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
NZ535592A (en) 2002-02-28 2006-07-28 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
PL372661A1 (en) 2002-03-29 2005-07-25 Pharmacia & Upjohn Company Llc. Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US20040132764A1 (en) 2002-10-23 2004-07-08 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibiotics for the treatment of infections in acidic environments
NZ540147A (en) 2002-11-28 2008-03-28 Astrazeneca Ab Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
GB0229521D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229526D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229518D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
TW200500360A (en) 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
EP1615916A1 (en) 2003-04-09 2006-01-18 Pharmacia & Upjohn Company LLC Antimicrobial 3.1.0 bicyclohexylphenyl-oxazolidinone derivatives and analogues
TWI378092B (en) 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
US20060270680A1 (en) 2003-06-03 2006-11-30 Goldberg Joel A Sulfonamide compounds and methods of making and using the same
WO2005012271A2 (en) 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
WO2005003087A2 (en) 2003-07-01 2005-01-13 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
MXPA06000228A (es) 2003-07-02 2006-06-27 Merck & Co Inc Antibioticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos.
US20070197541A1 (en) 2003-07-29 2007-08-23 Oyelere Adegboyega K Biaryl heterocyclic amines,amides, and sulfur-containing compounds and methods of making and using the same
JP2007514782A (ja) * 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물

Similar Documents

Publication Publication Date Title
JP2007500707A5 (cg-RX-API-DMAC10.html)
JP2013508297A5 (cg-RX-API-DMAC10.html)
RU2005127328A (ru) Ингибиторы гиразы и их применение
JP2013508299A5 (cg-RX-API-DMAC10.html)
RU2005100516A (ru) Производные 2-уреидо-6-гетероарил-3н-бензимидазол-6-карбоновой кислоты и родственные соединения в качестве ингибиторов гиразы и/или топоизомеразы iv для лечения бактериальных инфекций
JP2022515197A5 (cg-RX-API-DMAC10.html)
JP2013508298A5 (cg-RX-API-DMAC10.html)
JP2005533061A5 (cg-RX-API-DMAC10.html)
JP2003516404A5 (cg-RX-API-DMAC10.html)
ES2576497T3 (es) Compuesto de piperidina novedoso o sal del mismo
RU2003121398A (ru) Ингибиторы гиразы бактерий и их применения
JP2005502621A5 (cg-RX-API-DMAC10.html)
CA2412968A1 (en) Substituted pyridines as selective cyclooxygenase-2 inhibitors
JP2008526999A5 (cg-RX-API-DMAC10.html)
JP2003506354A5 (cg-RX-API-DMAC10.html)
JP2005509642A5 (cg-RX-API-DMAC10.html)
JP2018536641A5 (cg-RX-API-DMAC10.html)
JP2006507326A5 (cg-RX-API-DMAC10.html)
JP2009514894A5 (cg-RX-API-DMAC10.html)
DK1313697T3 (da) Immunregulatoriske forbindelser, derivater deraf samt anvendelse deraf
JP2007514782A (ja) ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
JP2009503024A5 (cg-RX-API-DMAC10.html)
JP2020519687A5 (cg-RX-API-DMAC10.html)
JP2012506908A5 (cg-RX-API-DMAC10.html)
RU2011121354A (ru) Синтетические миметики иммунной защиты и их применение